EU fines Teva Pharmaceutical for unfair competition

EU fines Teva Pharmaceutical for unfair competition

Brussels (Brussels Morning Newspaper) – Teva Pharmaceutical Industries Ltd. has been fined almost €463 million by the EU Commission for preventing fair competition by unfairly belittling a rival maker of a multiple sclerosis drug.

Teva is a global pharmaceutical firm … Read more

Continue reading EU fines Teva Pharmaceutical for unfair competition at The Brussels Morning Newspaper.

Leave a Reply

Your email address will not be published.